ANA Investigates, season 2 (2021)
Each month, during these 15-20 minute episodes, we delve into topics such as implicit bias in the workplace & patient care, designing and implementing a global teleneurology program, unbiased metagenomic next generation sequencing for diagnosis of CNS infection / inflammatory conditions, neurovirology, functional neuroimaging of functional movement disorders, and more!
Eligible ANA Investigates episodes are designated for AMA PRA Category 1 Credit(s)™. The system to claim CME will open at the end of the year following the last episode of each calendar year. You will have the ability to indicate the episodes for which you are seeking credit in one simple evaluation.
The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
CME is available for the following episodes in season 2:
Season 2 - September 2020
Episode 1: ANA Investigates Huntington's Disease - 9/2020 - Featuring Drs. Danny Bega, Jee Bang & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 2: ANA Investigates the Emerging Scholars Awardees - 11/2020 - Featuring Drs. Gus Davis, Juliane Gust, Jenn Orthmann-Murphy, Xilma Ortiz-Gonzalez, Michelle Johansen, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 3: ANA Investigates Neurologic Manifestations of the World Health Organization’s List of Pandemic and Epidemic Diseases - 1/2021 - Featuring Drs. Farrah Mateen & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 4: ANA Investigates Detection & Management of Neurologic Complications from COVID-19 Vaccines - 2/2021 - Featuring Drs. Avi Nath & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 5: ANA Investigates Tenecteplase in Stroke - 3/2021 - Featuring Drs. Bruce Campcell, Michelle Johanson, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 6: ANA Investigates Advancing Carotid Stenosis Treatment - 4/2021 - Featuring Drs. Seemant Chaturvedi, Cheryl Bushnell, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 7: ANA Investigates the Connection between Neurology & Psychiatry - 5/2021 - Featuring Drs. Rohit Das, Helen Mayberg, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: Dr. Mayberg owns intellectual property on DBS for depression, licensed to Abbott Labs; she is a consultant for Abbott Labs.
Episode 8: ANA Investigates Neurogenetics - 6/2021 - Featuring Drs. M. Elizabeth Ross & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 9: ANA Investigates Therapeutic Advancements in Neuroimmunology - 7/2021 - Featuring Drs. Jeffrey Gelfand, Rohini Samudralwar, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: Dr. Gelfand receives research support to UCSF for clinical trial from Rosch and Genetech; provides consulting to Biogen
Episode 10: ANA Investigates Central Nervous System Tumor Classification - 8/2021 - Featuring Drs. Lynne Taylor, Douglas Ney, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: None
Episode 11: ANA Investigates Dysautonomia - 9/2021 - Featuring Drs. Safwan Jaradeh, Megan Richie, & Adeline Goss - .5 AMA PRA Category 1 CreditsTM
Disclosures: Dr. Jaradeh disclosed the following relationships for CME purposes: Alnylam Pharma; Topic: Amyloid Neuropathy; Akcea Pharma; Topic: Amyloid Neuropathy; Takeda Pharma; Topic: Cyclic vomiting syndrome
Available Credit
- 5.50 AMA PRA Category 1 Credit™The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Neurological Association designates this Enduring material for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.50 Participation